Semicarbazide hydrochloride

CAS No. 563-41-7

Semicarbazide hydrochloride( —— )

Catalog No. M15050 CAS No. 563-41-7

Semicarbazide is the chemical compound with the formula OC(NH2)(N2H3).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Semicarbazide hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Semicarbazide is the chemical compound with the formula OC(NH2)(N2H3).
  • Description
    Semicarbazide is the chemical compound with the formula OC(NH2)(N2H3). This water-soluble white solid is also known as carbohydrazide. It is a derivative of urea.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    563-41-7
  • Formula Weight
    111.53
  • Molecular Formula
    CH6ClN3O
  • Purity
    >98% (HPLC)
  • Solubility
    Free soluble in Water
  • SMILES
    Cl.NNC(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Takahashi M, et al. Toxicol Pathol. 2010 Jun;38(4):598-605.
molnova catalog
related products
  • (25R)-3β,17α-dihydro...

    (25R)-3β,17α-dihydroxy-5α- spirostan-6-one3-O-α-L- rhamnopyranosyl-(1→2)-β- D-glucopyranoside is a natural product isolated from the bulbs of Lilium brownii var. viridulum.

  • CRF, bovine TFA (923...

    CRF, bovine (TFA) is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM.CRF, bovine is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM. CRF shows pEC50s of 11.16, 8.53 and 8.70 for human CRF1, human CRF2 and rat CRF2α.

  • TC-O 9311

    TC-O 9311 is a potent GPR139 agonist.